Paulina Mazur
Krakow, MA 30688, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Central and peripheral glutamatergic biomarkers delineate heterogeneous clinical phenotypes in olanzapine-treated schizophrenia.
Journal: Scientific reports
Published: October 29, 2025
Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia.
Journal: International journal of molecular sciences
Published: January 10, 2024
From periphery immunity to central domain through clinical interview as a new insight on schizophrenia.
Journal: Scientific reports
Published: November 18, 2023
SDS Electrophoresis on Gradient Polyacrylamide Gels as a Semiquantitative Tool for the Evaluation of Proteinuria.
Journal: Diagnostics (Basel, Switzerland)
Published: March 06, 2023
Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
Journal: Molecules (Basel, Switzerland)
Published: November 14, 2021
Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients.
Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients.
Journal: Medicina (Kaunas, Lithuania)
Published: November 14, 2021
Synergistic ROS-Associated Antimicrobial Activity of Silver Nanoparticles and Gentamicin Against Staphylococcus epidermidis.
Journal: International journal of nanomedicine
Published: January 17, 2020
Neutrophil to lymphocyte ratio at the early phase of acute pancreatitis correlates with serum urokinase-type plasminogen activator receptor and interleukin 6 and predicts organ failure.
Journal: Folia medica Cracoviensia
Published: February 13, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026